Roivant Sciences’ $200 Million Investment in Immunovant

Wachtell, Lipton, Rosen & Katz served as legal advisor to the special committee of the Immunovant board.Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here